The Commercial Use of Biodiversity PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download The Commercial Use of Biodiversity PDF full book. Access full book title The Commercial Use of Biodiversity by Kerry Ten Kate. Download full books in PDF and EPUB format.
Author: Kerry Ten Kate
Publisher: Routledge
ISBN: 1000699366
Category : Nature
Languages : en
Pages : 414
Get Book Here
Book Description
Originally published in 1999 The Commercial Use of Biodiversity examines how biodiversity and the genetic material it contains are now as valuable resources. Access to genetic resources and their commercial development involve a wide range of parties such as conservation and research institutes, local communities, government agencies and companies. Equitable partnerships are not only crucial to conservation and economic development but are also in the interests of business and often required by law. In this authoritative and comprehensive volume, the authors explain the provisions of the Convention on Biological Diversity on access and benefit-sharing, the effect of national laws to implement these, and aspects of typical contracts for the transfer of materials. They provide a unique sector-by-sector analysis of how genetic resources are used, the scientific, technological and regulatory trends and the different markets in Pharmaceuticals, Botanical Medicines, Crop Development, Horticulture, Crop Protection, Biotechnology (in fields other than healthcare and agriculture) and Personal Care and Cosmetics Products. This will be an essential sourcebook for all those in the commercial chain, from raw material collection to product discovery, development and marketing, for governments and policy-makers drafting laws on access and for all the institutions, communities and individuals involved in the conservation, use, study and commercialisation of genetic resources.
Author: Kerry Ten Kate
Publisher: Routledge
ISBN: 1000699366
Category : Nature
Languages : en
Pages : 414
Get Book Here
Book Description
Originally published in 1999 The Commercial Use of Biodiversity examines how biodiversity and the genetic material it contains are now as valuable resources. Access to genetic resources and their commercial development involve a wide range of parties such as conservation and research institutes, local communities, government agencies and companies. Equitable partnerships are not only crucial to conservation and economic development but are also in the interests of business and often required by law. In this authoritative and comprehensive volume, the authors explain the provisions of the Convention on Biological Diversity on access and benefit-sharing, the effect of national laws to implement these, and aspects of typical contracts for the transfer of materials. They provide a unique sector-by-sector analysis of how genetic resources are used, the scientific, technological and regulatory trends and the different markets in Pharmaceuticals, Botanical Medicines, Crop Development, Horticulture, Crop Protection, Biotechnology (in fields other than healthcare and agriculture) and Personal Care and Cosmetics Products. This will be an essential sourcebook for all those in the commercial chain, from raw material collection to product discovery, development and marketing, for governments and policy-makers drafting laws on access and for all the institutions, communities and individuals involved in the conservation, use, study and commercialisation of genetic resources.
Author: Oliver Deke
Publisher:
ISBN:
Category :
Languages : en
Pages : 40
Get Book Here
Book Description
Author: Michael K. Dorsey
Publisher:
ISBN:
Category :
Languages : en
Pages : 618
Get Book Here
Book Description
Author: Sarah Laird
Publisher:
ISBN: 9781138779099
Category : Business & Economics
Languages : en
Pages : 256
Get Book Here
Book Description
The access and benefit-sharing (ABS) policy process of the Convention on Biological Diversity (CBD), and wider discussions about the ethical and conservation issues arising from the commercial use of biodiversity and traditional knowledge, depend upon a well-developed understanding of the activities known broadly as 'bioprospecting'. However, the pace at which our understanding of genetic and other biological resources is accelerating, and market and industry trends are also undergoing constant change. This book provides information and insights into current practices and trends in biodiversity research and bioprospecting, including for potential medicines, food and cosmetics. It presents background information on markets, research and development, and explores recent extraordinary developments in science and technology and their implications for ABS policy development and implementation. The authors present a brief history of the commercial use of biodiversity, and review key trends across sectors. The book continues with chapters devoted to the main industry sectors, including pharmaceuticals and healthcare, agriculture, industrial process biotechnology and food and beverages. Each chapter includes explanatory boxes to describe key technologies and concepts which are less widely understood, as well as input from various stakeholders including industry representatives, NGOs and researchers. It concludes with a review of industry awareness of and engagement with the CBD, ABS and other policy processes. It is an invaluable resource for all concerned with commercial bioprospecting and the implementation of ABS laws and regulations, particularly in light of the adoption of the Nagoya Protocol.
Author: Ralph David Simpson
Publisher:
ISBN:
Category : Biodiversity conservation
Languages : en
Pages : 62
Get Book Here
Book Description
Author: Carmen Richerzhagen
Publisher: Routledge
ISBN: 1135025134
Category : Business & Economics
Languages : en
Pages : 286
Get Book Here
Book Description
During the last ten years the enormous global loss of biodiversity has received remarkable attention. Among the numerous approaches undertaken to stop or lessen this process, access and benefit-sharing (ABS), a market-based approach, has emerged as among the most prominent. In theory, ABS turns biodiversity and genetic resources from an open access good to a private good and creates a market for genetic resources. It internalizes the resources’ positive externalities by pricing the commercial values for research and development and makes users pay for it. Users’ benefits are shared with the resource holders and set incentives for the sustainable use and the conservation of biodiversity. Carmen Richerzhagen, however, finds that in practice there are significant questions about the effectiveness of the approach in the protection of biodiversity and about the fair and equitable sharing of benefits arising from the commercialization. Utilizing the empirical findings of three case studies of biodiversity-providing countries - Costa Rica, the Philippines and Ethiopia - and one case study of a community of user countries, the European Union (EU), Richerzhagen examines the effectiveness of ABS through the realization of its own objectives.
Author: Dan Biller
Publisher: OECD
ISBN:
Category : Business & Economics
Languages : en
Pages : 144
Get Book Here
Book Description
Governments and the business sector are increasingly recognising the potential of biodiversity products and services; markets which can help to promote the sustainable use and conservation of biodiversity. Some are already being profitably marketed, but private markets also need to be supported by appropriate public policies. This publication provides a conceptual framework to help identify and promote the use of markets in the biodiversity policy arena, and draws on the findings of a joint OECD/World Bank workshop held in Paris in January 2001. It discusses the concept of 'public goods' and considers four examples of emerging markets: organic agriculture; sustainable forestry; non-timber forest products, such as natural cosmetics and herbal medicines; and genetic resources.
Author: Evanson Chege Kamau
Publisher: Routledge
ISBN: 1317511174
Category : Business & Economics
Languages : en
Pages : 418
Get Book Here
Book Description
National implementation of the Convention on Biological Diversity (CBD) provisions has yielded enough challenges for providers and users of genetic resources and associated traditional knowledge alike. The Nagoya Protocal brings novel ideas for resolving the challenges plaguing the Access and Benefit-Sharing (ABS) process in general and non-commercial research in particular. This is one of the first books to address research cooperation and facilitated access for non-commercial biodiversity research. It uniquely offers concrete and practicable solutions based on experiences of researchers and administrative officials with ABS, and on the interpretation of the Nagoya Protocol on how free and lively taxonomic research can be ensured while at the same time observing obligations of obtaining prior informed consent and sharing of benefits. This book will be useful to students of International Environmental Law, International Biodiversity Law, Intellectual Property Law, Climate Law and Law of Indigenous Populations. With foreword from Executive Secretary CBD, Braulio Ferreira de Souza Dias.
Author: Ueli Baruffol
Publisher:
ISBN:
Category : Biodiversity conservation
Languages : en
Pages : 178
Get Book Here
Book Description
Author: Santiago Carrizosa
Publisher: IUCN
ISBN: 2831708168
Category : Law
Languages : en
Pages : 332
Get Book Here
Book Description
The book aims to address the lack of information on the experiences of others by providing a comparative analysis of national access and benefit-sharing laws and policies in the 41 Pacific Rim countries that signed the CBD. It provides key insights on the main characteristics of selected access and benefit-sharing (ABS) policies and laws, their development, and implementation process. It contains a detailed comparative analysis of existing laws and policies. It presents four case studies of countries with regulations in place and contrasts them with four case studies of countries that are struggling to develop their regulations. It ends by discussing options of an international regime on ABS and a summary analysis of the main lessons and recommendations from the study.
